# The Role of Neuromodulators in Refractory Functional Dyspepsia

> **NCT05099913** · NA · UNKNOWN · sponsor: **RenJi Hospital** · enrollment: 220 (estimated)

## Conditions studied

- Dyspepsia
- Functional Gastrointestinal Disorders
- Antidepressant Discontinuation Syndrome
- Antidepressant Drug Adverse Reaction

## Interventions

- **DRUG:** Deanxit

## Key facts

- **NCT ID:** NCT05099913
- **Lead sponsor:** RenJi Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-08-01
- **Primary completion:** 2022-10-01
- **Final completion:** 2022-12-30
- **Target enrollment:** 220 (ESTIMATED)
- **Last updated:** 2022-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05099913

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05099913, "The Role of Neuromodulators in Refractory Functional Dyspepsia". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT05099913. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*